Abstract
Clopidogrel resistance is associated with increased periprocedural neurologic events after carotid stenting. Ticagrelor offers an improved resistance profile, but the bleeding risk of this medication has not been assessed with transfemoral carotid artery stenting (tfCAS) or transcarotid artery revascularization (TCAR). Therefore, we examined the safety and efficacy of preoperative DAPT with aspirin (ASA)/ticagrelor vs ASA/clopidogrel in patients undergoing tfCAS or TCAR.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
